Study: People who took Paxlovid had reduced risk of 'long COVID' symptoms

Paxlovid, the anti-viral drug designed to combat death and hospitalization from COVID-19, may also help cut the chances that a person will develop 'long haul COVID,' according to a new study.

Top Videos